Financials & FinTech research, Galliano’s Financials Research

Victor Galliano

Victor Galliano is an experienced equity banks analyst, having covered Latin America banks and non-bank financials for over 12 years, as well as more recently covering the Italian banks. He has worked in sell side equity research for 30 years in a career spanning Barclays, HSBC, BBVA LatInvest, Barings and NatWest.
Galliano's Financials Research provides fundamental research in Emerging Markets financials, including FinTech, as well as financials in select Developed Markets.
The investment style applied is generally value oriented, although Growth At Reasonable Price (GARP) strategies can also be used where appropriate. Our investment research approach aim is often contrarian, looking to capitalise on overly sceptical or optimistic consensus views. In terms of valuation techniques, the focus is on PBV ratio to ROE, PE multiples and dividend yield, as well as the application of PEG ratios and, where appropriate, Sum of the Parts (SOTP) valuations.

Financials & FinTech research

Emerging Market Overweights Series.  Part 2:  Argentinian Consumer Discretionary

Emerging Market Overweights Series.  Part 3:  Taiwan Tech

MercadoLibre:  The Jewel in the Latam Crown

MercadoLibre (MELI US): Chinks in the Digital Armour

Brazil Payment Companies; Rotating from Growth to Value - Buy Cielo, Sell Pagseguro, StoneCo

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Financials & FinTech, EM & Developed Markets

Galliano’s Financials Research

Galliano's Financials Research provides fundamental research in Emerging Markets financials, including FinTech, as well as financials in select Developed Markets.

The investment style applied is generally value oriented, although Growth At Reasonable Price (GARP) strategies can also be used where appropriate. 

Our investment research approach aim is often contrarian, looking to capitalise on overly sceptical or optimistic consensus views. In terms of valuation techniques, the focus is on PBV ratio to ROE, PE multiples and dividend yield, as well as the application of PEG ratios and, where appropriate, Sum of the Parts (SOTP) valuations.

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/mercadolibre-inc" target="_blank" data-smartkarma-citation="entities:27954:1" rel="noopener">MercadoLibre Inc (MELI US)</a> shares have continued to re-rate, supported by positive 3Q20 results</li>
<li>E-commerce and payments growth rates are accelerating, as MELI is a key LatAm beneficiary of the pandemic shift to e-commerce and digital payments</li>
<li>Consensus estimate revisions are positive, as shown in the chart, and this has powered share price momentum</li>
<li>On valuations, however, we believe that these are stretched; the 2021 revenue multiple is double that of <a href="https://www.smartkarma.com/entities/alibaba-group-holding-ltd" target="_blank" data-smartkarma-citation="entities:787:1" rel="noopener">Alibaba Group (BABA US)</a> </li>
<li>Even on our generous assumptions for a simple SOTP valuation, MELI valuations look stretched</li>
<li>In the light of the positive vaccine news, we believe that tech pandemic beneficiaries, including MELI, are exposed to sentiment-driven investor rotation out of high valuation tech names and into value stocks</li>
<li>Risks to our cautious view on MELI include a continued fast pace of e-commerce and digital payments activity in LatAm driving revenue, EBITDA and net profit higher</li>
</ul>



MercadoLibre Inc (MELI US) shares have continued to re-rate, supported by positive 3Q20 results
E-commerce and payments growth rates are accelerating, as MELI is a key LatAm beneficiary of the pandemic shift to e-commerce and digital payments
Consensus estimate revisions are positive, as shown in the chart, and this has powered share price momentum
On valuations, however, we believe that these are stretched; the 2021 revenue multiple is double that of Alibaba Group (BABA US) 
Even on our generous assumptions for a simple SOTP valuation, MELI valuations look stretched
In the light of the positive vaccine news, we believe that tech pandemic beneficiaries, including MELI, are exposed to sentiment-driven investor rotation out of high valuation tech names and into value stocks
Risks to our cautious view on MELI include a continued fast pace of e-commerce and digital payments activity in LatAm driving revenue, EBITDA and net profit higher


メルカド・リブレ（MELI US）：株価はファンダメンタルズに牽引されるものの、割高なバリュエーションの影響を受ける